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Abstract
The voltage-gated hERG (human-Ether-à-go-go Related Gene) K+ channel plays 
a fundamental role in cardiac action potential repolarization. Loss-of-function mu-
tations or pharmacological inhibition of hERG leads to long QT syndrome, whilst 
gain-of-function mutations lead to short QT syndrome. A recent open channel 
cryo-EM structure of hERG represents a significant advance in the ability to inter-
rogate hERG channel structure-function. In order to suppress protein aggregation, 
a truncated channel construct of hERG (hERGT) was used to obtain this structure. 
In hERGT cytoplasmic domain residues 141 to 350 and 871 to 1,005 were removed 
from the full-length channel protein. There are limited data on the electrophysiologi-
cal properties of hERGT channels. Therefore, this study was undertaken to determine 
how hERGT influences channel function at physiological temperature. Whole-cell 
measurements of hERG current (IhERG) were made at 37°C from HEK 293 cells ex-
pressing wild-type (WT) or hERGT channels. With a standard +20 mV activating 
command protocol, neither end-pulse nor tail IhERG density significantly differed 
between WT and hERGT. However, the IhERG deactivation rate was significantly 
slower for hERGT. Half-maximal activation voltage (V0.5) was positively shifted 
for hERGT by ~+8 mV (p < .05 versus WT), without significant change to the ac-
tivation relation slope factor. Neither the voltage dependence of inactivation, nor 
time course of development of inactivation significantly differed between WT and 
hERGT, but recovery of IhERG from inactivation was accelerated for hERGT (p < .05 
versus WT). Steady-state “window” current was positively shifted for hERGT with 
a modest increase in the window current peak. Under action potential (AP) voltage 
clamp, hERGT IhERG showed modestly increased current throughout the AP plateau 
phase with a significant increase in current integral during the AP. The observed con-
sequences for hERGT IhERG of deletion of the two cytoplasmic regions may reflect 
changes to electrostatic interactions influencing the voltage sensor domain.
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1 |  INTRODUCTION
Cardiac action potential repolarization involves the coordi-
nated activity of several key potassium (K+) ion channels 
(Tamargo, Caballero, Gomez, Valenzuela, & Delpon, 2004). 
The rapid delayed rectifier K+ current, IKr, plays an import-
ant role in repolarization from ventricular action potential 
(AP) plateau voltages, with current progressively increas-
ing during the plateau before declining during terminal re-
polarization (Hancox, Levi, & Witchel,  1998; Mitcheson 
& Hancox,  1999; Rocchetti, Besana, Gurrola, Possani, & 
Zaza, 2001; Sanguinetti & Tristani-Firouzi, 2006). This final 
repolarization phase is mediated by the distinct, inwardly 
rectifying K+ current, IK1 (Mitcheson & Hancox,  1999; 
Shimoni, Clark, & Giles,  1992; Zaza, Rochetti, Brioschi, 
Cantadori, & Ferroni,  1998). In addition to contributing 
to repolarization during APs, IKr can regulate diastolic de-
polarization of cells in pacemaker regions of the cardiac 
conduction system, through continued deactivation of IKr fol-
lowing AP repolarization (Mitcheson & Hancox, 1999; Ono 
& Ito, 1995). IKr is carried by channels encoded by human-
Ether-à-go-go Related Gene (hERG, alternative nomencla-
ture KCNH2) (Sanguinetti, Jiang, Curran, & Keating, 1995; 
Trudeau, Warmke, Ganetzky, & Robertson,  1995). hERG 
channel current (IhERG), like IKr, is characterized by rapid 
voltage-dependent inactivation, which plays a critical role 
in shaping the channel's contribution to ventricular AP re-
polarization (Hancox, McPate, El Harchi, & Zhang,  2008; 
Sanguinetti & Tristani-Firouzi,  2006; Vandenberg, Walker, 
& Campbell,  2001). The channel's relatively fast inactiva-
tion/recovery from inactivation kinetics together with slower 
deactivation kinetics also means that hERG/IKr channels can 
generate outward transient currents that oppose premature 
stimuli late in repolarization/early in diastole (Lu et al., 2001; 
Vandenberg et al., 2001).
Given the important physiological roles of hERG/IKr 
channels, it is unsurprising that hERG mutations have adverse 
consequences. Loss-of-function hERG mutations underpin 
the LQT2 form of congenital long QT syndrome (LQTS), 
whilst gain-of-function mutations underlie the SQT1 form of 
congenital short QT syndrome (SQTS); both conditions pre-
dispose to malignant arrhythmias and sudden death (Hancox, 
Whittaker, Du, Stuart, & Zhang, 2018; Sanguinetti & Tristani-
Firouzi,  2006). hERG channels also have a remarkable 
sensitivity to pharmacological inhibition by diverse pharma-
ceuticals linked to the drug-induced form of acquired LQTS 
(Hancox et al., 2008; Sanguinetti & Tristani-Firouzi, 2006). 
Due to this, novel pharmaceuticals must be tested for ac-
tivity against the hERG channel (Gintant,  2008; Hancox 
et al., 2008). Current understanding of hERG channel struc-
ture-function has derived from a combination of functional 
mutagenesis studies and in silico modeling. For most of the 
period since the first electrophysiological studies of hERG 
in 1995 (Sanguinetti et  al.,  1995; Trudeau et  al.,  1995), in 
silico reconstructions of hERG structure have relied on ho-
mology modeling; in 2017 this changed with the publication 
of the first cryo electron microscopy (cryo-EM)-derived 
hERG structure (Wang & MacKinnon, 2017). This structure, 
of an open channel with voltage sensors captured in a depo-
larized conformation, provides unprecedented opportunities 
to better understand hERG channel gating and pharmacol-
ogy (Butler, Helliwell, Zhang, Hancox, & Dempsey,  2020; 
Robertson & Morais-Cabral, 2019). It is important to note, 
however, that because the full-length wild-type (WT) hERG 
protein tends to aggregate during purification (Su, Brown, 
Wang, & MacKinnon, 2016; Wang & MacKinnon, 2017), the 
wild-type hERG construct used to obtain the cryo-EM struc-
ture contained deletions of two segments of the channel (see 
Figure 1a; residues 141–350 and 871–1005), each predicted 
to be disordered (Wang & MacKinnon, 2017). IhERG kinetics 
data for the truncated construct, hERGT, are limited to date, 
showing a modest (+5 mV) shift in voltage-dependent acti-
vation, whilst the channel retained sensitivity to inhibition by 
the high affinity inhibitors dofetilide and astemizole (Wang & 
MacKinnon, 2017). A question arises, therefore, as to the ex-
tent to which the kinetics of IhERG carried by hERGT resemble 
or differ from those of the intact WT channel. Consequently, 
this study was undertaken to compare IhERG carried by intact 
hERG with that carried by hERGT.
2 |  METHODS
2.1 | Mutagenesis
The hERGT 814 amino acid truncation construct in which two 
segments of the complete 1,159 amino acid protein (141–350 
and 871–1005) were deleted (Wang & MacKinnon, 2017), 
was generated by Mutagenex Inc (Suwanee, GA 30,024, 
USA) from a WT hERG construct template in a vector 
of modified pcDNA3 used in our laboratory. Competent 
DH5α Escherichia coli (Invitrogen, Paisley, UK) were 
transformed using standard procedures, DNA was puri-
fied using a Endotoxin-free plasmid DNA purification kit 
K E Y W O R D S
hERG, IKr, KCNH2, Kv11.1, Long QT Syndrome, LQT2, potassium channel, rapid delayed 
rectifier
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(Neumann-Neander-Str., Germany, Macherey-Nagel), and 
the mutation was confirmed by sequencing of the entire 
open reading frame (Eurofins MWG Operon, Ebersberg, 
Germany).
2.2 | Cell culture and transfection
Human embryonic kidney (HEK 293) cells (European 
Collection of Cell Cultures, Porton Down, UK) were used 
to study the effects of the WT and hERGT on IhERG kinetics 
and profile under action potential (AP) voltage clamp. These 
cells were maintained at 37°C, 5% CO2 in Dulbecco's mini-
mum essential medium with Glutamax-1 (DMEM; Gibco, 
Paisley, UK). This was supplemented with 10% fetal bovine 
serum. Cells were transiently transfected with 1μg of cDNA 
plasmids encoding WT or hERGT using Lipofectamine 2000 
(Invitrogen, Paisley, UK) according to the manufacturer's in-
structions. Expression plasmid encoding CD8 (0.15μg) was 
also added (in pIRES, donated by Dr I Baró, University of 
Nantes, France) to be used as a successful marker of trans-
fection. Successfully transfected cells (positive to CD8) were 
identified using Dynabeads® (Invitrogen, Paisley, UK). This 
approach, which utilizes polystyrene microspheres coated 
with CD8 antibody that adhere to CD8+ cells, has long been 
proposed to be valuable for visual identification of trans-
fected cells for electrophysiology experiments (Jurman, 
Boland, Liu, & Yellen, 1994). Electrophysiological record-
ing experiments were performed 12–48 hr after transfection 
(a range within that of prior studies from our laboratory; 
Butler, Zhang, Stuart, Dempsey, & Hancox, 2019; Melgari 
et al., 2015; Zhang et al., 2016).
2.3 | Solutions for 
electrophysiological recordings
Once the coverslip containing cells was put in the recording 
chamber, cells were superfused with normal Tyrode's con-
taining (in mM): 140 NaCl, 4 KCl, 2.5 CaCl2, 1 MgCl2, 10 
Glucose, and 5 HEPES (titrated to pH of 7.45 with NaOH) 
(Butler et al., 2019; Melgari et al., 2015; Zhang et al., 2016). 
The pipette dialysis solution for hERG current (IhERG) meas-
urement contained (in mM): 130 KCl, 1 MgCl2, 5 EGTA, 5 
MgATP, and 10 HEPES (titrated to a pH of 7.2 with KOH) 
(Butler et al., 2019; Melgari et al., 2015; Zhang et al., 2016).
2.4 | Experimental protocols
Whole-cell conventional and human AP voltage clamp (“AP 
clamp”) recordings of IhERG were made at 37 ± 1°C by using 
an Axopatch 200B amplifier (Axon Instruments, Foster City, 
CA, USA). Patch pipettes were fire polished to 2.5–4 MΩ. 
Between 70% and 80% of the electrode series resistance could 
be compensated. Data were recorded via a Digidata 1440A 
interface (Molecular Devices, Sunnyvale, CA, USA). Data 
digitization rates were 10–25 kHz during all protocols and an 
appropriate bandwidth of 2–10kHz was set on the amplifier. 
Currents elicited under “AP clamp” were corrected online 
for P/N leak subtraction using an interspersed P/4 protocol 
(Butler, Zhang, Stuart, Dempsey, & Hancox, 2018; McPate 
et al., 2009; Melgari et al., 2015). The specific voltage pro-
tocols used experimentally are detailed within the relevant 
figures and associated Results.
Half-maximal activation (V0.5) voltage values were ob-
tained by normalizing IhERG tail values (I) at −40  mV fol-
lowing differing voltage commands to the maximal IhERG tail 
value observed during the voltage protocol (Imax). The re-
sulting values were plotted against corresponding command 
voltage (Vm), and fitted by a Boltzmann equation of the form:
Half-maximal inactivation voltage (V0.5) was obtained 
from normalized plots of voltage-dependent availability, 
using the following equation:
Where the inactivation parameter occurs within the range 
0 – 1, Vm represents the repolarization voltage used to influ-
ence IhERG availability, V0.5 is the half-maximal inactivation 
voltage and k is the slope factor describing the IhERG inacti-
vation relation.
Continuous plots of voltage-dependent activation and 
inactivation relations were obtained from half-maximal ac-
tivation/inactivation voltage (V0.5) and slope factor (k) values 
derived from experimental data, by calculation of activation 
and inactivation parameter values at 2 mV intervals between 
−150 and +100  mV, using equations 1 and 2 (Colenso, 
Sessions, Zhang, Hancox, & Dempsey,  2013; Zhang, 
Colenso, Sessions, Dempsey, & Hancox, 2011).
Action potential (AP) clamp experiments were conducted, 
as described previously, using a human epicardial ventricular 
AP waveform generated by the ten Tusscher–Noble–Noble–
Panfilov ventricular tissue model (ten McPate et  al.,  2009; 
Tusscher, Noble, Noble, & Panfilov, 2004).
2.5 | Data presentation and 
statistical analysis
Data were analyzed using Clampfit 10.2 (Axon Instruments), 
Excel 2016 (Microsoft, Redmond, WA), Origin 2018b 
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8 (Graphpad Inc, La Jolla, CA, USA) software. Total charge 
carried by WT and hERGT channels during AP commands was 
determined by integrating currents using Origin 2018b (Butler 
et  al.,  2018). Statistical comparisons were made using the 
Student's t test, or two way analysis of variance (ANOVA) fol-
lowed by Bonferroni post hoc test, as appropriate. P values less 
than 0.05 were taken as being statistically significant.
3 |  RESULTS
3.1 | IhERG carried by hERGT channels 
during a standard voltage “step” protocol
Figure 1a illustrates the truncated hERGT construct compared 
with WT hERG. The first deleted region encoding residues 
141–350 (cut between 140 and 351), removed most of the 
N-linker region that connects the N terminal Per-ARNT-Sim 
(PAS) domain with S1 of the voltage sensor domain (VSD); 
the second deleted region encoding residues 871–1005 (cut be-
tween 870 to 1,006), eliminated much of the long cytoplasmic 
C terminal tail that follows the cytoplasmic cyclic nucleotide 
binding homology domain (CNBHD). In initial experiments, 
the profile of IhERG was compared between WT and hERGT 
channels using a standard IhERG protocol comprised of a 2  s 
depolarization from −80 to +20 mV, followed by repolariza-
tion to −40 mV. A brief (50 ms) prepulse from −80 to −40 mV 
preceded the +20 mV command, to provide a reference value 
for IhERG tail amplitude measurement (Melgari et  al.,  2015; 
Zhang et al., 2016) WT IhERG (Figure 1b, left panel) exhibited 
well-established characteristics: current development during 
the applied depolarization with a resurgent IhERG “tail” elic-
ited during a repolarizing step to −40  mV. IhERG carried by 
hERGT (Figure  1b, right panel) exhibited a similar overall 
profile. The IhERG tail and end-pulse current density were re-
spectively 151.40 ± 22.28 pA/pF and 83.43 ± 13.93 pA/pF for 
hERGT (n = 21); for WT hERG the comparable values were 
169.48 ± 25.10 pA/pF and 81.92 ± 12.65 pA/pF, respectively 
(n = 21). There was no significant difference in either value be-
tween WT and hERGT (p = .59 and 0.94 for tail and end-pulse 
current density respectively, Student's t test). Tail current deac-
tivation was fitted with a biexponential function to derive fast 
and slow (τf and τs) time constant values (Zhou et al., 1998) 
(Figure 1c). The mean τs value (describing the slow compo-
nent of deactivation) was significantly larger for IhERG carried 
by hERGT than WT channels (1.73 ± 0.14 s for hERGT and 
1.35 ± 0.09 s for WT, p <  .05; n = 21 for each, Student's t 
test). τf and the relative proportion of fast/slow deactivation 
showed no significant change compared to WT (p = .63 and 
0.59 respectively, Student's t test). Thus, hERGT slowed IhERG 
deactivation by increasing τs.
3.2 | WT and hERGT current–voltage (I–V) 
relationships compared
The voltage dependence of WT and hERGT IhERG was com-
pared using 2  s depolarizing voltage steps from a holding 
F I G U R E  1  hERGT structure, current 
profile, and deactivation. (a) Schematic 
diagram showing truncated hERGT 
compared to WT hERG domains (indicated 
by use of different colors). In hERGT, 
amino acid residues between 140–351 and 
870–1006 were removed (regions encoding 
residues 141–350 and 871–1005 were 
removed). (b) Example current (IhERG) 
traces for WT hERG (left panel) and hERGT 
(right panel) with corresponding voltage 
protocol shown in the lower panels. (c) Bar 
chart shows comparison of fast and slow 
deactivation time constants between WT 
and hERGT (n = 21 for each of WT and 
hERGT, * denotes statistical significance of 
p < .05; unpaired t test)
140 351 870 1006
1159
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potential of −80 mV to potentials between −40 and +60 mV 
(Butler et al., 2019; Zhang et al., 2011). Representative traces 
at selected potentials are shown in Figure 2a for WT (upper 
left panel) and hERGT (upper right panel) IhERG, with the 
corresponding voltage protocol underneath. The normalized 
mean I–V data are shown in Figure 2b. For WT IhERG, the 
end-pulse current increased progressively with depolariza-
tion up to  ~  0mV, declining after 10  mV, giving rise to a 
well-established bell shaped current–voltage (I–V) relation 
(Figure 2b, left panel). For hERGT, the I–V relation showed 
a similar profile, but peaked at +10 mV, with an apparent 
modest rightward shift of the end-pulse I–V relation com-
pared to WT hERG. 2-way ANOVA analysis did not reveal 
overall significant differences between WT and hERGT in 
the normalized end-pulse I–V relations (p = .11). However, 
such analysis did show an overall significant difference be-
tween WT and hERGT in the normalized tail I–V relations 
(p < .05), although the conservative Bonferroni post-test did 
not identify significance at particular potentials in the tested 
range.
Scrutiny of the representative traces for WT and hERGT 
IhERG in Figure 2a shows that for test voltages up to ~0 mV, 
hERGT IhERG was activated to smaller extent than was that 
for WT hERG. Normalized I–V relations for IhERG tails were 
used to quantify voltage-dependent activation, with fits to 
equation 1 used to derive half-maximal activation voltage 
(V0.5) and slope (k) values (right panel of Figure  2b). The 
V0.5 and k values for WT IhERG activation derived from the 
fits were −15.96  ±  1.89mV and 7.52  ±  0.55mV (n  =  9). 
For hERGT the comparable values were: −8.29  ±  3.10mV 
and 5.47  ±  1.01mV, respectively (n  =  7; p  <  .05 for V0.5 
and p  =  .11 for k versus WT, Student's t test). Thus, the 
V0.5 describing the voltage dependence of activation of 
IhERG for hERGT was significantly shifted by ~+8mV com-
pared to the WT channel (cf ~+5  mV reported by Wang 
& MacKinnon,  2017). This rightward shift in voltage-de-
pendent activation of hERGT was associated with a slower 
rise-time of currents during the activating command at some 
voltages. Thus, exponential fitting of the current activated 
by the test pulse to −10  mV yielded rise-time τ values of 
930.85 ± 133.78 ms for hERGT and 554.26 ± 75.84 ms for WT 
hERG (p < .05). During the command to 0 mV, the rise-time 
τ was 577.61 ± 113.09 ms for hERGT and 296.28 ± 56.92 ms 
for WT (p < .05). At + 20 mV, however, there was no signifi-
cant difference between hERGT (188.39 ± 64.30 ms) and WT 
hERG (78.27 ± 6.77 ms; p = .07).
3.3 | Comparison of inactivation 
characteristics between WT and hERGT IhERG
We proceeded to determine the voltage dependence of 
IhERG inactivation (availability) by using the protocol 
shown in the upper panel of Figure  3a, in the protocol 
F I G U R E  2  Current–voltage (I–V) 
relationship for WT and hERGT IhERG. (a) 
Upper panels show representative IhERG 
families of currents for WT hERG (left 
panel) and hERGT (right panel). Test 
pulses were applied at 10 mV increments 
between −40 mV and +60 mV, with only 
selected traces being shown for clarity of 
display. Corresponding test potentials of 
the voltage protocol are indicated in the 
lower panel (start-to-start interval of 12 s 
between successive voltage steps). (b) Mean 
I–V relations for end-pulse currents (left 
panel) and mean normalized tail currents 
I–V relations (right panel); for each of 
WT (n = 9) and hERGT (n = 7), data were 
normalized to the maximal currents recorded 
during the protocol. Tail current data were 
fitted with equation 1 to give the V0.5 and k 
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(Zhang et  al.,  2011; Butler et al., 2019). An initial depo-
larizing command to +40  mV was used to activate and 
then inactivate IhERG; following this, a 2 ms brief repolar-
izing command was applied to a range of potentials (in 
10 mV increments down to −140 mV) to relieve inactiva-
tion to varying extents. This was followed by a third step 
to +40 mV. The magnitude of peak current elicited by the 
third step reflected the extent of availability induced by 
the second step (Butler et  al.,  2019; Zhang et  al.,  2011). 
Figure  3a shows representative traces from WT (middle 
left panel) and hERGT IhERG (middle right panel) respec-
tively. To correct for possible deactivation during this pro-
tocol as in previous work from our laboratory, a method 
described by Zou et al was used (McPate, Duncan, Milnes, 
Witchel, & Hancox,  2005; Zhang et  al.,  2011; Zou, Xu, 
& Sanguinetti,  1998). Peak current amplitudes during the 
third pulse were obtained by single exponential fitting of 
the currents and extrapolation to the start of the third step 
(McPate et al., 2005; Zhang et al., 2011; Zou et al., 1998). 
Peak currents during the third step were then normalized to 
maximal current and mean data were plotted as shown in 
Figure  3b, Boltzmann fitting this relation, using equation 
2, yielded an inactivation V0.5 value of −66.33 ± 5.38 mV 
(k = 18.27 ± 1.69; n = 10) for WT and −59.99 ± 3.92 mV 
for hERGT IhERG (k = 19.96 ± 2.26, n = 10, p > .05 for V0.5 
(p = .35) and for k (p = .56) compared with WT).
The time course of development of inactivation was quan-
tified by mono-exponential fitting of the decline of IhERG 
transients following repolarization steps to −120  mV in 
this protocol. The inactivation τ-values obtained from this 
are shown in Figure 3c; these were 1.07 ± 0.08 ms (n = 10) 
and 1.43 ± 0.16 ms for WT and hERGT IhERG respectively 
(n = 10). Although there was a trend towards a slowed in-
activation time course for hERGT IhERG, this did not attain 
statistical significance (p = .07, Student t test).
The time course of recovery of IhERG from inactivation was 
assessed using a protocol (Figure 4) in which a depolariza-
tion step to +40 mV was first applied for 500 ms to activate 
and inactivate IhERG; this was followed by a repolarisation 
step to −40 mV (a voltage close to which peak IhERG occurs 
during physiological repolarization (McPate et al., 2009)) for 
increasing periods of time (between 2 and 20 ms) to release 
F I G U R E  3  Voltage and time-
dependence of inactivation for WT and 
hERGT IhERG. (a) Upper panels show 
the whole protocol used to interrogate 
inactivation, with the highlighted area 
shown enlarged in the main panels. Main 
panels show representative traces of WT 
(Left panel) and hERGT (right panel) IhERG, 
focusing on the current profile during the 
second and start of the third steps of the 
protocol, only selected traces shown for 
clarity of display. Relevant portion of 
voltage protocol shown below currents. (b) 
IhERG availability plots for WT (n = 10) 
and hERGT (n = 10). Data were fitted with 
equation 2 to give the V0.5 and k values 
presented in the Results text. (c) Bar chart 
showing the time constant for development 
of inactivation of WT (n = 10) and 
hERGT IhERG (n = 10) obtained by single 
exponential fitting of the currents elicited 
following the repolarizing step to −120 mV.
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F I G U R E  4  Time course of recovery 
from inactivation for WT and hERGT. 
(a) Whole protocol used to assess the 
time course of recovery of IhERG from 
inactivation, with highlighted area shown 
in the lower panel of panel 4B. (b) 
Representative traces of WT and hERGT 
IhERG with corresponding portion of the 
voltage protocol shown below the current 
traces. (c) Mean normalized current 
plot with time. The dashed line denotes 
mono-exponential fit to WT data (open 
circles, n = 5). The solid line denotes 
mono-exponential fit to hERGT (filled 
circles, n = 5). (d) Bar chart showing the 
comparison of recovery time constants for 
WT (n = 5) and hERGT IhERG (n = 5, * 
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F I G U R E  5  WT and hERGT window 
current. (a) Superimposed activation 
(solid line) and inactivation (availability, 
dashed line) relations for WT (black, left 
panel) and hERGT (gray, right panel) IhERG 
respectively. Activation and inactivation 
parameters were calculated at 2-mV 
intervals, using the V0.5 and k values 
obtained from fitting the experimental 
data. (b) “Window current” (the product of 
activation-inactivation parameters) plotted 
against membrane potential to show the 
steady-state WT (in black) and hERGT (in 
gray) IhERG window.
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inactivation. A second depolarization step to +40 mV was then 
applied for 100 ms and the IhERG measured, (Figure 4a). From 
this, the rate of recovery of IhERG from inactivation was quan-
tified by mono-exponentially fitting the transient peak cur-
rents following different duration steps to  −40 mV (McPate 
et al., 2009; Zhang et al., 2011). Representative traces for WT 
and hERGT IhERG during this protocol are shown in Figure 4b 
with the lower panel showing the corresponding voltage pro-
tocol. The initial two hERGT records with this protocol (upper 
right panel of Figure  4b) attained a greater proportion of 
maximal current amplitude than was the case for WT hERG 
(upper left panel of Figure 4b), suggestive of faster recovery 
from inactivation. Peak outward transient currents were nor-
malized to the maximal current observed during the protocol 
and the resulting mean data were plotted against the duration 
of the repolarization step. These relations were fitted with a 
mono-exponential function, giving τ values of 1.77 ± 0.06 ms 
for WT (n = 5) and 1.06 ± 0.16 ms for hERGT (n = 5; p < .05, 
Student's t test). Thus, hERGT IhERG exhibited significantly ac-
celerated recovery of inactivation.
The V0.5 and k values obtained from the activation and 
inactivation fits to experimental data were used to calculate 
activation and inactivation parameters for IhERG carried by 
WT and hERGT over a wide range of voltages, as plotted in 
Figure 5a, left and right panel, respectively. The product of 
activation and inactivation parameters at each membrane po-
tential was calculated and plotted as shown in Figure 5b, in 
order to obtain “window” current for WT hERG and hERGT 
(Butler et al., 2019; Zhang et al., 2011). The IhERG window 
was slightly rightward shifted and exhibited a modest in-
crease in the peak of the window for hERGT.
3.4 | IhERG profile during ventricular AP 
clamp compared between WT and hERGT
The AP clamp technique enables membrane potential “his-
tory” to be taken into account during dynamic activation 
of an ionic current of interest (Hancox et al., 1998; Noble, 
Varghese, Kohl, & Noble,  1998; Zhou et  al.,  1998). It 
therefore allows currents to be measured with their nor-
mal physiological time course and voltage dependence. 
Figure  6a shows mean normalized IhERG traces for WT 
(left panel) and hERGT (gray trace in right panel with WT 
current superimposed in black), elicited by the ventricular 
AP command shown. WT IhERG was initially small, then 
increased progressively through the AP plateau phase up 
to a peak before declining during terminal AP repolari-
sation; the maximal current for WT hERG occurred at 
−29.84 ± 1.98mV (n = 10) (Hancox et al., 1998; McPate 
et al., 2005, 2009). The mean normalized IhERG for hERGT 
appeared to be bigger throughout the AP plateau phase, 
peaking slightly earlier during the AP. We measured the 
current integral (area under curve, normalized to cell ca-
pacitance) for each channel. Figure 6b compares the total 
charge carried by WT and hERGT under AP clamp, the 
current integral for hERGT was significantly larger than 
that for WT hERG (p <  .05, Student's t test, n = 10 for 
each). While plots of the mean voltage at which maximal 
current was recorded during repolarization (Figure  6c) 
showed a modest shift of ~+4 mV (to −25.81 ± 2.51 mV; 
n = 10) for hERGT compared to the WT channel, this dif-
ference did not attain statistical significance (p  =  .25, 
Student's t test).
F I G U R E  6  IhERG during AP clamp 
for WT and hERGT. (a) Ventricular AP 
command waveform overlying mean 
normalized value of IhERG for WT (left 
panel in black, n = 10) and hERGT (right 
panel in gray, n = 10, with corresponding 
WT current superimposed in black). (b) 
Comparison of the total charge carried 
by each channel (n = 10 for each) during 
each action potential, calculated by 
integrating the current traces, normalized 
to cell capacitance, * denotes statistical 
significance of p < .05; Student's t test. (c) 
Comparison of the voltage at which the peak 
currents occurred during AP repolarization 
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4 |  DISCUSSION
To our knowledge, the only prior information on the elec-
trophysiological properties of the hERGT deletion con-
struct comes from the original cryo-EM study (Wang & 
MacKinnon,  2017), reporting a +5mV shift in activation 
V0.5 at ambient temperature. Here, we observed a ~+8mV 
activation V0.5 shift at 37°C, together with a rightward shift 
in window current, slowed deactivation, slightly accelerated 
recovery from inactivation, and increased current integral 
during an applied AP command. Several aspects of these 
findings are worthy of discussion.
4.1 | Relating observed changes in kinetics 
to channel structure?
Similar to other voltage-gated K+ channels, functional hERG 
channels are comprised of a tetramer of subunits containing 
six transmembrane segments, with a voltage sensor domain 
(VSD) comprised of S1–S4 segments. In contrast to many 
other Kv channels, however, the cryo-EM structure of hERG 
shows a lack of domain-swapping and the VSD is in close 
apposition to the pore domain of the same subunit (Butler 
et  al.,  2020; Robertson & Morais-Cabral,  2019; Wang & 
MacKinnon,  2017). Voltage-dependent inactivation oc-
curs at the outer mouth of the channel, with comparison of 
hERGT and hERGTS-S631A (impaired inactivation) mutant 
structures showing subtle differences in the position of side 
chains at the outer portion of the selectivity filter (Robertson 
& Morais-Cabral, 2019; Wang & MacKinnon, 2017).
Deletion of the N terminal hERG-specific domain be-
tween residues 138–373 has previously been reported to pro-
duce a negative shift in voltage-dependent activation of IhERG, 
(Viloria, Barros, Giraldez, Gomez-Varela, & de la Pena, 2000), 
implicating this region in modulation of activation kinetics. 
Within this stretch of the N terminus lies a “KIKER” se-
quence (K362-R366). When the positively charged residues 
in this sequence were substituted by glutamic acid (EIEEE), 
a markedly negative (~ −41 mV) voltage-shift in activation 
V0.5 was observed (Saenen, Labro, Raes, & Snyders, 2006). 
On the other hand, when the negatively charged glutamate 
was substituted by arginine (E365R) a marked positive shift 
in activation V0.5 was observed. E365R also showed slightly 
slowed deactivation (Saenen et al., 2006). The authors of this 
study concluded that the modulatory effects of the proximal 
domain on hERG gating are largely electrostatic and local-
ized to the KIKER region (Saenen et al., 2006). The N ter-
minal deletion region of hERGT includes residues 141–350 
upstream of the KIKER sequence. It is notable that a larger 
proximal deletion of residues 141–380 (hERGTS), which in-
cludes the KIKER sequence, resulted in a marked negative 
shift of V0.5 (−20  mV (Wang & MacKinnon,  2017)). It is 
plausible, therefore, that the 141–350 deletion influences the 
availability of KIKER residues to undergo electrostatic inter-
actions with the VSD, producing a modest effect on activa-
tion kinetics seen here.
Deletion of the hERG N terminus has been found to alter 
hERG channel inactivation, likely by removing an N termi-
nus interaction with the internal S4–S5 linker region of the 
channel (Wang, Trudeau, Zappia, & Robertson, 1998). This 
is believed to account for altered rectification of heteromeric 
hERG1a/1b channels, which possess fewer hERG1a N ter-
mini to interact with the S4–S5 linker than do tetrameric 
hERG 1a channels (Sale et al., 2008). We found that inacti-
vation kinetics of the hERGT channel were similar to those of 
WT hERG, with the only observed difference being a signif-
icant acceleration in the recovery of IhERG from inactivation; 
this may reflect a subtle difference in N terminal interactions 
with the S4–S5 linker in the hERGT channel.
Slow deactivation of hERG involves an interaction be-
tween the N terminal PAS domain and the C terminal 
cyclic nucleotide binding domain (CNBD; (Gustina & 
Trudeau, 2011)). The cryo-EM structures for hERG identi-
fied a cytosolic ring structure with the PAS domain of one 
subunit interacting with the CNBD domain of its neighbor 
(Wang & MacKinnon, 2017). hERG channels with deletions 
of CNBD (deletion of residue 749–872) show accelerated de-
activation kinetics, whereas deletion of C terminal residues 
873–1159 leaves WT activation and deactivation properties 
unaffected (Gustina & Trudeau, 2011). Muskett et al impli-
cated interactions between N terminal residues 1–26 and res-
idues 843, 847 and 850 in the CNBD in IhERG deactivation 
(Muskett et  al.,  2011). These residues are proximal to the 
deleted region from 871 to 1,005 in hERGT, however, so it is 
not obvious how this deletion could influence deactivation of 
hERGT IhERG. On the other hand, residues in the S4–S5 linker 
provide potential interaction sites for domains that influence 
stability of the open state and, thereby, deactivation kinet-
ics (Ng et al., 2012). Altered N terminal S4–S5 interactions 
may therefore account for the slowed IhERG deactivation of 
hERGT channels. Some studies reporting substantial C ter-
minal deletions in hERG showed these to be associated with 
reduced current magnitude (Mihic, Chauhan, Gao, Oudit, & 
Tsushima, 2011; Nof et al., 2010), which is not the case for 
hERGT here. The basis for this difference is not clear, though 
it is notable that hERGT involves an excision of part of the C 
terminus that leaves more than 150 of the final residues intact, 
while the mutations in these two studies (Mihic et al., 2011; 
Nof et al., 2010) involved frameshifts and premature stop co-
dons. Thus, they do not mirror the C terminal change made 
to hERGT.
An additional point of note regarding the hERGT con-
struct is that we did not observe significantly reduced func-
tional expression (measured as current density) between 
WT and hERGT constructs. A number of long QT 2 (LQT2) 
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missense mutations have been reported within the deleted 
regions (Anderson et  al.,  2014; Tester, Will, Haglund, & 
Ackerman, 2005). In the N terminus, this includes G238S, 
G306W, S320L, R328C (Tester et  al.,  2005) and P334L 
(Lupoglazoff et al., 2001). In the distal C terminus this in-
cludes A913V and R1005Q (Anderson et al., 2014); the latter 
residue is part of the RXR C terminal endoplasmic reticulum 
(ER) retention signal (Kupershmidt et al., 2002). The C ter-
minal deletion in hERGT disrupts this ER retention signal. 
Clearly the overall effects of deletion of the two stretches of 
N and C termini in hERGT are not to produce channels with 
an LQT phenotype.
4.2 | Implications of hERGT properties for 
interpretation of pharmacology in light of the 
hERG cryo-EM structure
A motivator for this study was an apparent deviation be-
tween mutagenesis experiments and docking simulations 
using the hERG cryo-EM structure for a minimally struc-
tured, high affinity hERG inhibitor (Helliwell et al., 2018). 
In the cryo-EM structure, the side chains of F656, which are 
important for hERG inhibition by multiple drugs (reviewed 
in Butler et al., 2020), project away from the central pore; 
a small clockwise rotation of the inner (S6) helix of the 
hERG pore from its configuration in the cryo-EM struc-
ture was suggested to optimize F656 side chain positions 
for drug interactions consistent with electrophysiologi-
cal data (Chen, Seebohm, & Sanguinetti, 2002; Helliwell 
et al., 2018). An independent study has also reported dif-
ficulty using docking to the cryo-EM structure in recapitu-
lating experimental data that implicate residue T623 (near 
the base of the selectivity filter/pore helix) in R-roscovitine 
binding (Cernuda et al., 2019). Two broad possibilities can 
account for such differences between in vitro and dock-
ing observations: (i) deletions necessary for successful 
protein purification might affect the channel conformation 
in ways that are adverse to drug binding and (ii) the chan-
nel is essentially normal, but the structure obtained from 
cryo-EM may have been captured in a nonoptimal con-
figuration for drug binding (Butler et al., 2020; Robertson 
& Morais-Cabral, 2019). In the cryo-EM structure the S4 
voltage sensor was captured in the activated (depolar-
ized), configuration at a nominal potential of 0 mV, and 
the inner helical gate is open (Wang & MacKinnon, 2017). 
The information in this study most relevant to this situ-
ation is the steady-state window IhERG (Figure  5). 0  mV 
is close to the peak of the window current for hERGT, 
while it is a little beyond the peak of the window current 
for the WT channel. It seems unlikely that this small dif-
ference would result in large conformational differences 
between the pore of WT and hERGT channels. Thus, it 
seems more likely that the cryo-EM structure captured a 
low affinity open state in which the positions of binding 
residues are nonoptimally configured for interaction with 
some drugs (Helliwell et al., 2018), although recent stud-
ies indicate that the energetic barriers to reorientation of 
Phe side chains into configurations more optimal for in-
teraction with drugs may be small (Dickson, Velez-Vega, 
& Duca, 2020; Negami, Araki, Okuno, & Terada, 2019). 
There are only limited data available on the pharmacology 
of hERGT channels (Wang & MacKinnon, 2017) and, with 
the properties of hERGT IhERG now more fully character-
ized, we suggest that future comparison be made of ef-
fects on drug binding of mutations to key binding residues 
in the canonical drug binding between WT and hERGT. 
If such mutations similarly affect drug binding to the two 
channels, this will fully eliminate a role for the deletions 
in hERGT in influencing drug binding; in that event, the 
“snapshot” conformation in which the cryo-EM structure 
was obtained will be the likely explanation for differences 
between experimental and docking findings (Cernuda 
et al., 2019; Helliwell et al., 2018).
4.3 | Limitations and conclusions
This study has focused on comparing WT and hERGT IhERG 
under basal conditions. The deleted regions in hERGT con-
tain phosphorylation sites for modulation by protein ki-
nases A and C (PKA and PKC) (Cockerill et al., 2007; Cui, 
Melman, Palma, Fishman, & McDonald,  2000; Thomas 
et al., 2003). The well-known K897T polymorphism, which 
also introduces a phosphorylation site (Gentile et al., 2008) 
lies within the portion of the C terminus deleted in hERGT. 
Consequently, while our data indicate that the differences 
between WT and hERGT IhERG are modest under basal re-
cording conditions, there could be substantial differences in 
the response of the two channels to PKA or PKC agonism. 
In this study, we have not compared pharmacological re-
sponses of WT and hERGT channels, but this is warranted 
for future studies. We conclude that at physiological tem-
perature, hERGT channels exhibit rightward voltage-shifted 
activation, slowed deactivation and faster recovery from in-
activation than does WT hERG. Steady-state window current 
is also rightward shifted for hERGT channels. These changes 
are likely to result, at least in part, from altered electrostatic 
interactions between the intracellular N terminus and other 
domains of the hERG channel.
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